SCA functional index: A useful compound performance measure for spinocerebellar ataxia

Neurology

Volumn 71, Issue 7, 2008, Pages 486-492

  Schmitz Hubsch T ^a   Giunti, P ^b   Stephenson, D A ^b   Globas, C ^c   Baliko, L ^d   Sacca F ^e   Mariotti, C ^f   Rakowicz, M ^g   Szymanski, S ^h   Infante, J ⁱ   Van De Warrenburg, B P C ^j   Timmann, D ^k   Fancellu, R ^f   Rola, R ^g   Depondt, C ^l   Schols L ^c   Zdzienicka, E ^g   Kang, J S ^m   Dohlinger S ⁿ   Kremer, B ^j   Melegh, B ^o   Filla, A ^e   Klockgether, T ^a   more..

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Hungary   (Hungary)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f DEPARTMENT OF NEUROSURGERY   (Italy)

^g INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^h ST JOSEF HOSPITAL   (Germany)

ⁱ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^k UNIVERSITY OF DUISBURG ESSEN   (Germany)

^l ERASME HOSPITAL   (Belgium)

^m GOETHE UNIVERSITY   (Germany)

ⁿ UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^o UNIVERSITY OF PÉCS   (Hungary)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT ASSESSMENT; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION; DISABILITY; MIDDLE AGED; MOTOR PERFORMANCE; PATHOPHYSIOLOGY; PHYSIOLOGY;

DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS; SPINOCEREBELLAR ATAXIAS;

EID: 53749103910     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000324863.76290.19     Document Type: Article

References (21)

1. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871-882.
2. Cohen JA, Cutter GR, Fischer JS, et al. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Arch Neurol 2001;58:961-967.
3. Kalkers NF, Bergers L, de Groot, V, et al. Concurrent validity of the MS Functional Composite using MRI as a biological disease marker. Neurology 2001;56:215-219.
4. Rudick RA, Cutter G, Baier M, et al. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Neurology 2001;56:1324-1330.
5. Schwid SR, Petrie MD, Murray R, et al. A randomized controlled study of the acute and chronic effects of cooling therapy for MS. Neurology 2003;60:1955-1960.
6. Kragt JJ, van der Linden, FA, Nielsen JM, Uitdehaag BM, Polman CH. Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis. Mult Scler 2006;12:594-598.
7. Lynch DR, Farmer JM, Wilson RL, Balcer LJ. Performance measures in Friedreich ataxia: potential utility as clinical outcome tools. Mov Disord 2005;20:777-782.
8. Lynch DR, Farmer JM, Tsou AY, et al. Measuring Fried-reich ataxia: complementary features of examination and performance measures. Neurology 2006;66:1711-1716.
9. Subramony SH, May W, Lynch D, et al. Measuring Frie-dreich ataxia: Interrater reliability of a neurologic rating scale. Neurology 2005;64:1261-1262.
10. Schmitz-Hübsch T, du Montcel, ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale [erratum in 2006;67:299]. Neurology 2006;66:1717-1720.
11. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136-142.
12. Smith YA, Hong E, Presson C. Normative and validation studies of the Nine-hole Peg Test with children. Percept Mot Skills 2000;90:823-843.
13. Kennedy DM, Stratford PW, Wessel J, Gollish JD, Penney D. Assessing stability and change of four performance measures: a longitudinal study evaluating outcome following total hip and knee arthroplasty. BMC Musculoskel Disord 2005;6:3.
14. Fischer JS, Jak AJ, Kniker JE, Rudick RA, Cutter G. Multiple Sclerosis Functional Composite Administration and Scoring Manual. National Multiple Sclerosis Society 2001.
15. Oxford-Grice K, Vogel KA, Le V, Mitchell A, Muniz S, Vollmer MA. Adult norms for a commercially available Nine Hole Peg Test for finger dexterity. Am J Occup Ther 2003;57:570-573.
16. Bischoff HA, Stähelin HB, Monsch AU, et al. Identifying a cut-off point for normal mobility: a comparison of the timed 'up and go' test in community-dwelling and institutionalised elderly women. Age Ageing 2003;32: 315-320.
17. Ruff RM, Parker SB. Gender- and age-specific changes in motor speed and eye-hand coordination in adults: normative values for the Finger Tapping and Grooved Pegboard Tests. Percept Mot Skills 1993;76:1219-1230.
18. Bohannon RW. Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants. Age Ageing 1997;26:15-19.
19. Steffen TM, Hacker TA, Mollinger L. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther 2002;82:128- 137.
20. Williams EN, Carroll SG, Reddihough DS, Phillips BA, Galea MP. Investigation of the timed 'up & go' test in children. Dev Med Child Neurol 2005;47:518-524.
21. Kaufman M, Moyer D, Norton J. The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite. Mult Scler 2000;6:286-290.